HTFL Insider Trading Activity and SEC Form 4 Filings
HTFL insider trading summary
Over the past 12 months, insiders at Heartflow, Inc. (HTFL) reported 56 sales worth $599.6M by 9 insiders and 1 open-market purchase worth $1.1M by 1 insider on SEC Form 4. Net insider selling was $598.6M.
Latest HTFL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 22, 2026 | Campbell Rogers | Chief Medical Officer | Sell | $1.3M (23,933 @ $55.01) |
| Oct 12, 2026 | John C.M. Farquhar | Chief Executive Officer | Sell | $1.9M (38,900 @ $49.57) |
| Sep 18, 2026 | Campbell Rogers | Chief Medical Officer | Sell | $987K (19,682 @ $50.15) |
| Sep 18, 2026 | Vikram Verghese | Chief Financial Officer | Sell | $851K (16,766 @ $50.75) |
| Sep 17, 2026 | Vikram Verghese | Chief Financial Officer | Sell | $380K (7,579 @ $50.11) |
| Sep 15, 2026 | Vikram Verghese | Chief Financial Officer | Sell | $33K (668 @ $50.01) |
| Sep 14, 2026 | Vikram Verghese | Chief Financial Officer | Sell | $231K (4,593 @ $50.24) |
| Sep 11, 2026 | John C.M. Farquhar | Chief Executive Officer | Sell | $195K (3,890 @ $50.00) |
| Sep 11, 2026 | Vikram Verghese | Chief Financial Officer | Sell | $1.5M (29,714 @ $50.06) |
| Sep 10, 2026 | John C.M. Farquhar | Chief Executive Officer | Sell | $1.6M (35,010 @ $46.42) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.